{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:41:19Z","timestamp":1787020879381,"version":"build-2736575974"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,30]],"date-time":"2020-01-30T00:00:00Z","timestamp":1580342400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,1,30]],"date-time":"2020-01-30T00:00:00Z","timestamp":1580342400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005847","name":"Health and Medical Research Fund","doi-asserted-by":"crossref","award":["15161021"],"award-info":[{"award-number":["15161021"]}],"id":[{"id":"10.13039\/501100005847","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Preterm birth accounts for 75% of perinatal deaths and more than 50% of long-term neurological disabilities. For a singleton pregnancy, progesterone treatment is effective in prevention of preterm birth in women with an asymptomatic short cervix or a history of preterm birth. However, a large proportion of preterm births still is not currently preventable. The aim of this study is to determine whether early universal use of oral progesterone before 14\u2009+\u20090\u2009weeks of gestation can prevent preterm birth better than universal screening of cervical length at 18\u2009+\u20090 to 23\u2009+\u20096\u2009weeks of gestation, followed by progesterone treatment in those with a short cervix in singleton pregnancy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This is a multicenter, randomized, double-blind, placebo-controlled trial registered with ClinicalTrials.gov on 12 February 2018. Eligible consecutive pregnant women with singleton gestation attending antenatal outpatient clinics will be recruited after receiving counseling and signing the written consent form. Transvaginal cervical length measurement will be performed at recruitment (before 14\u2009+\u20090\u2009weeks of gestation) and between 18\u2009+\u20090 and 23\u2009+\u20096\u2009weeks of gestation. After randomization, women will be randomly assigned to either the treatment group (oral dydrogesterone 10\u2009mg three times daily) or the placebo group, and medication will be started before 14\u2009+\u20090\u2009weeks of gestation. Assigned groups will be unblinded if the cervical length is \u2264\u200925\u2009mm between 18\u2009+\u20090 and 23\u2009+\u20096\u2009weeks of gestation, and the management option for short cervix will be discussed (oral progesterone, vaginal progesterone, or cervical cerclage). The primary outcome is preterm birth before 37\u2009+\u20090\u2009weeks of gestation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Progesterone is used extensively in part of the in vitro fertilization program as luteal phase support, and it is not associated with teratogenicity. Universal progesterone supplementation may be a better approach to prevent preterm birth. This large, multicenter, randomized, double-blind, placebo-controlled trial will provide the best evidence, leading to the best strategy for the prevention of preterm birth.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      ClinicalTrials.gov,\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT03428685\">NCT03428685<\/jats:ext-link>\n                      . Registered on 12 February 2018.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13063-020-4067-z","type":"journal-article","created":{"date-parts":[[2020,1,30]],"date-time":"2020-01-30T09:03:04Z","timestamp":1580374984000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Early universal use of oral progesterone for prevention of preterm births in singleton pregnancy (SINPRO study): protocol of a multicenter, randomized, double-blind, placebo-controlled trial"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1207-6494","authenticated-orcid":false,"given":"Ka Wang","family":"Cheung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mimi Tin Yan","family":"Seto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest Hung Yu","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,30]]},"reference":[{"issue":"7467","key":"4067_CR1","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1136\/bmj.329.7467.675","volume":"329","author":"J Tucker","year":"2004","unstructured":"Tucker J, McGuire W. Epidemiology of preterm birth. BMJ. 2004;329(7467):675\u20138.","journal-title":"BMJ"},{"issue":"9606","key":"4067_CR2","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0140-6736(08)60074-4","volume":"371","author":"RL Goldenberg","year":"2008","unstructured":"Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet. 2008;371(9606):75\u201384.","journal-title":"Lancet"},{"issue":"9832","key":"4067_CR3","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1016\/S0140-6736(12)60560-1","volume":"379","author":"L Liu","year":"2012","unstructured":"Liu L, Johnson HL, Cousens S, Perin J, Scott S, Lawn JE, et al. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet. 2012;379(9832):2151\u201361.","journal-title":"Lancet"},{"issue":"9814","key":"4067_CR4","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/S0140-6736(11)61577-8","volume":"379","author":"MK Mwaniki","year":"2012","unstructured":"Mwaniki MK, Atieno M, Lawn JE, Newton CR. Long-term neurodevelopmental outcomes after intrauterine and neonatal insults: a systematic review. Lancet. 2012;379(9814):445\u201352.","journal-title":"Lancet"},{"issue":"1","key":"4067_CR5","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.puhe.2013.09.014","volume":"128","author":"AL Soilly","year":"2014","unstructured":"Soilly AL, Lejeune C, Quantin C, Bejean S, Gouyon JB. Economic analysis of the costs associated with prematurity from a literature review. Public Health. 2014;128(1):43\u201362.","journal-title":"Public Health"},{"issue":"9832","key":"4067_CR6","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1016\/S0140-6736(12)60820-4","volume":"379","author":"H Blencowe","year":"2012","unstructured":"Blencowe H, Cousens S, Oestergaard MZ, Chou D, Moller AB, Narwal R, et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet. 2012;379(9832):2162\u201372.","journal-title":"Lancet"},{"issue":"9","key":"4067_CR7","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1056\/NEJM199602293340904","volume":"334","author":"JD Iams","year":"1996","unstructured":"Iams JD, Goldenberg RL, Meis PJ, Mercer BM, Moawad A, Das A, National Institute of Child Health and Human Development Maternal Fetal Medicine Unit Network, et al. The length of the cervix and the risk of spontaneous premature delivery. N Engl J Med. 1996;334(9):567\u201372.","journal-title":"N Engl J Med"},{"issue":"2 Pt 1","key":"4067_CR8","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1097\/01.AOG.0000275287.08520.4a","volume":"110","author":"CY Spong","year":"2007","unstructured":"Spong CY. Prediction and prevention of recurrent spontaneous preterm birth. Obstet Gynecol. 2007;110(2 Pt 1):405\u201315.","journal-title":"Obstet Gynecol"},{"issue":"11","key":"4067_CR9","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1001\/jama.286.11.1340","volume":"286","author":"J Owen","year":"2001","unstructured":"Owen J, Yost N, Berghella V, Thom E, Swain M, Dildy GA 3rd, et al. Mid-trimester endovaginal sonography in women at high risk for spontaneous preterm birth. JAMA. 2001;286(11):1340\u20138.","journal-title":"JAMA"},{"issue":"5","key":"4067_CR10","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1002\/uog.5323","volume":"31","author":"JM Crane","year":"2008","unstructured":"Crane JM, Hutchens D. Transvaginal sonographic measurement of cervical length to predict preterm birth in asymptomatic women at increased risk: a systematic review. Ultrasound Obstet Gynecol. 2008;31(5):579\u201387.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"24","key":"4067_CR11","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1056\/NEJMoa035140","volume":"348","author":"PJ Meis","year":"2003","unstructured":"Meis PJ, Klebanoff M, Thom E, Dombrowski MP, Sibai B, Moawad AH, et al. Prevention of recurrent preterm delivery by 17\u03b1-hydroxyprogesterone caproate. N Engl J Med. 2003;348(24):2379\u201385.","journal-title":"N Engl J Med"},{"issue":"2","key":"4067_CR12","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ajog.2017.11.576","volume":"218","author":"R Romero","year":"2018","unstructured":"Romero R, Conde-Agudelo A, Da Fonseca E, O\u2019Brien JM, Cetingoz E, Creasy GW, et al. Vaginal progesterone for preventing preterm birth and adverse perinatal outcomes in singleton gestations with a short cervix: a meta-analysis of individual patient data. Am J Obstet Gynecol. 2018;218(2):161\u201380.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"4067_CR13","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/uog.9017","volume":"38","author":"SS Hassan","year":"2011","unstructured":"Hassan SS, Romero R, Vidyadhari D, Fusey S, Baxter JK, Khandelwal M, et al. Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol. 2011;38(1):18\u201331.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"1","key":"4067_CR14","doi-asserted-by":"publisher","first-page":"100.e1","DOI":"10.1016\/j.ajog.2016.01.192","volume":"215","author":"BD Einerson","year":"2016","unstructured":"Einerson BD, Grobman WA, Miller ES. Cost-effectiveness of risk-based screening for cervical length to prevent preterm birth. Am J Obstet Gynecol. 2016;215(1):100.e1\u20137.","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"4067_CR15","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.ajog.2015.09.102","volume":"214","author":"A Conde-Agudelo","year":"2016","unstructured":"Conde-Agudelo A, Romero R. Vaginal progesterone to prevent preterm birth in pregnant women with a sonographic short cervix: clinical and public health implications. Am J Obstet Gynecol. 2016;214(2):235\u201342.","journal-title":"Am J Obstet Gynecol"},{"key":"4067_CR16","doi-asserted-by":"publisher","unstructured":"Dodd JM, Jones L, Flenady V, Cincotta R, Crowther CA. Prenatal administration of progesterone for preventing preterm birth in women considered to be at risk of preterm birth. Cochrane Database Syst Rev. 2013;(7):CD004947. https:\/\/doi.org\/10.1002\/14651858.CD004947.pub3.","DOI":"10.1002\/14651858.CD004947.pub3"},{"issue":"3","key":"4067_CR17","first-page":"379","volume":"98","author":"SL Bloom","year":"2001","unstructured":"Bloom SL, Yost NP, McIntire DD, Leveno KJ. Recurrence of preterm birth in singleton and twin pregnancies. Obstet Gynecol. 2001;98(3):379\u201385.","journal-title":"Obstet Gynecol"},{"issue":"5","key":"4067_CR18","doi-asserted-by":"publisher","first-page":"453.e1","DOI":"10.1016\/j.ajog.2006.09.009","volume":"196","author":"F Facchinetti","year":"2007","unstructured":"Facchinetti F, Paganelli S, Comitini G, Dante G, Volpe A. Cervical length changes during preterm cervical ripening: effects of 17-\u03b1-hydroxyprogesterone caproate. Am J Obstet Gynecol. 2007;196(5):453.e1\u20134 discussion 421.","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"4067_CR19","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/uog.14742","volume":"45","author":"KO Kagan","year":"2015","unstructured":"Kagan KO, Sonek J. How to measure cervical length. Ultrasound Obstet Gynecol. 2015;45(3):358\u201362.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"1","key":"4067_CR20","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ajog.2018.03.028","volume":"219","author":"A Conde-Agudelo","year":"2018","unstructured":"Conde-Agudelo A, Romero R, Da Fonseca E, O\u2019Brien JM, Cetingoz E, Creasy GW, et al. Vaginal progesterone is as effective as cervical cerclage to prevent preterm birth in women with a singleton gestation, previous spontaneous preterm birth, and a short cervix: updated indirect comparison meta-analysis. Am J Obstet Gynecol. 2018;219(1):10\u201325.","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"4067_CR21","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.ijgo.2014.06.019","volume":"127","author":"AS Hui","year":"2014","unstructured":"Hui AS, Lao TT, Leung TY, Schaaf JM, Sahota DS. Trends in preterm birth in singleton deliveries in a Hong Kong population. Int J Gynaecol Obstet. 2014;127(3):248\u201353.","journal-title":"Int J Gynaecol Obstet"},{"issue":"4","key":"4067_CR22","first-page":"283","volume":"30","author":"SY Hui","year":"2013","unstructured":"Hui SY, Chor CM, Lau TK, Lao TT, Leung TY. Cerclage pessary for preventing preterm birth in women with a singleton pregnancy and a short cervix at 20 to 24 weeks: a randomized controlled trial. Am J Perinatol. 2013;30(4):283\u20138.","journal-title":"Am J Perinatol"},{"issue":"2","key":"4067_CR23","doi-asserted-by":"publisher","first-page":"124.e1","DOI":"10.1016\/j.ajog.2011.12.003","volume":"206","author":"R Romero","year":"2012","unstructured":"Romero R, Nicolaides K, Conde-Agudelo A, Tabor A, O\u2019Brien JM, Cetingoz E, et al. Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient data. Am J Obstet Gynecol. 2012;206(2):124.e1\u201319.","journal-title":"Am J Obstet Gynecol"},{"key":"4067_CR24","first-page":"CD009154","volume":"7","author":"M van der Linden","year":"2015","unstructured":"van der Linden M, Buckingham K, Farquhar C, Kremer JA, Metwally M. Luteal phase support for assisted reproduction cycles. Cochrane Database Syst Rev. 2015;7:CD009154.","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"4067_CR25","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/S0015-0282(16)48490-6","volume":"43","author":"LJ Resseguie","year":"1985","unstructured":"Resseguie LJ, Hick JF, Bruen JA, Noller KL, O\u2019Fallon WM, Kurland LT. Congenital malformations among offspring exposed in utero to progestins, Olmsted County, Minnesota, 1936-1974. Fertil Steril. 1985;43(4):514\u20139.","journal-title":"Fertil Steril"},{"issue":"1","key":"4067_CR26","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/0029-7844(94)00341-A","volume":"85","author":"L Raman-Wilms","year":"1995","unstructured":"Raman-Wilms L, Tseng AL, Wighardt S, Einarson TR, Koren G. Fetal genital effects of first-trimester sex hormone exposure: a meta-analysis. Obstet Gynecol. 1995;85(1):141\u20139.","journal-title":"Obstet Gynecol"},{"issue":"10033","key":"4067_CR27","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1016\/S0140-6736(16)00350-0","volume":"387","author":"JE Norman","year":"2016","unstructured":"Norman JE, Marlow N, Messow CM, Shennan A, Bennett PR, Thornton S, et al. Vaginal progesterone prophylaxis for preterm birth (the OPPTIMUM study): a multicentre, randomised, double-blind trial. Lancet. 2016;387(10033):2106\u201316.","journal-title":"Lancet"},{"issue":"12","key":"4067_CR28","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1111\/aogs.13236","volume":"96","author":"S Ashoush","year":"2017","unstructured":"Ashoush S, El-Kady O, Al-Hawwary G, Othman A. The value of oral micronized progesterone in the prevention of recurrent spontaneous preterm birth: a randomized controlled trial. Acta Obstet Gynecol Scand. 2017;96(12):1460\u20136.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"1","key":"4067_CR29","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ajogmf.2019.03.001","volume":"1","author":"RC Boelig","year":"2019","unstructured":"Boelig RC, Della Corte L, Ashoush S, McKenna D, Saccone G, Rajaram S, et al. Oral progesterone for the prevention of recurrent preterm birth: systematic review and metaanalysis. Am J Obstet Gynecol MFM. 2019;1(1):50\u201362.","journal-title":"Am J Obstet Gynecol MFM"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-020-4067-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13063-020-4067-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-020-4067-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T19:25:35Z","timestamp":1611861935000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-020-4067-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,30]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["4067"],"URL":"https:\/\/doi.org\/10.1186\/s13063-020-4067-z","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,30]]},"assertion":[{"value":"28 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Central ethical approval has been obtained from the Institutional Review Board of the University of Hong Kong\/Hospital Authority Hong Kong West Cluster (UW 17-308). We will not begin recruiting at other centers in the trial until local ethical approval has been obtained. Informed consent will be obtained from all study participants.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"121"}}